Clinical Trial to Evaluate the Safety and Immunogenicity of Mumps Vaccine
Clinical trial NCT04364399 · COMPLETED
Trial details
- NCT number
- NCT04364399
- Sponsor
- Sinovac (Dalian) Vaccine Technology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-18
- Primary completion
- 2020-11-18
- Enrollment
- 920
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.